You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor–Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors
|
|---|---|
| Published in |
Cancer Immunology Research, June 2022
|
| DOI | 10.1158/2326-6066.cir-22-0040 |
| Pubmed ID | |
| Authors |
Sanghyun P. Kim, Nolan R. Vale, Nikolaos Zacharakis, Sri Krishna, Zhiya Yu, Billel Gasmi, Jared J. Gartner, Sivasish Sindiri, Parisa Malekzadeh, Drew C. Deniger, Frank J. Lowery, Maria R. Parkhurst, Lien T. Ngo, Satyajit Ray, Yong F. Li, Victoria Hill, Maria Florentin, Robert V. Masi, Biman C. Paria, Noam Levin, Alakesh Bera, Elizabeth A. Hedges, Agnes Choi, Praveen D. Chatani, Anup Y. Parikh, Shoshana Levi, Samantha Seitter, Yong-Chen Lu, Zhili Zheng, Todd D. Prickett, Li Jia, Jonathan M. Hernandez, Chuong D. Hoang, Paul F. Robbins, Stephanie L. Goff, Richard M. Sherry, James C. Yang, Steven A. Rosenberg |
X Demographics
The data shown below were collected from the profiles of 53 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 25 | 47% |
| Greece | 2 | 4% |
| United Kingdom | 1 | 2% |
| Tanzania, United Republic of | 1 | 2% |
| Switzerland | 1 | 2% |
| Israel | 1 | 2% |
| Spain | 1 | 2% |
| Unknown | 21 | 40% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 31 | 58% |
| Scientists | 12 | 23% |
| Practitioners (doctors, other healthcare professionals) | 8 | 15% |
| Science communicators (journalists, bloggers, editors) | 2 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 96 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 96 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 23 | 24% |
| Student > Ph. D. Student | 14 | 15% |
| Unspecified | 7 | 7% |
| Student > Doctoral Student | 5 | 5% |
| Student > Master | 5 | 5% |
| Other | 10 | 10% |
| Unknown | 32 | 33% |
| Readers by discipline | Count | As % |
|---|---|---|
| Immunology and Microbiology | 17 | 18% |
| Biochemistry, Genetics and Molecular Biology | 15 | 16% |
| Medicine and Dentistry | 9 | 9% |
| Unspecified | 7 | 7% |
| Agricultural and Biological Sciences | 6 | 6% |
| Other | 8 | 8% |
| Unknown | 34 | 35% |
Attention Score in Context
This research output has an Altmetric Attention Score of 49. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 April 2024.
All research outputs
#870,879
of 25,837,817 outputs
Outputs from Cancer Immunology Research
#84
of 1,588 outputs
Outputs of similar age
#20,784
of 446,760 outputs
Outputs of similar age from Cancer Immunology Research
#2
of 35 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,588 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.1. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 446,760 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 35 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.